Curtis Medical Investments (Letchworth) Limited 31/12/2024 iXBRL

Company registration number: 04165193

Curtis Medical Investments (Letchworth) Limited

Unaudited filleted financial statements

31 December 2024

Curtis Medical Investments (Letchworth) Limited

Contents

Directors and other information

Accountants report

Statement of financial position

Statement of changes in equity

Notes to the financial statements

Curtis Medical Investments (Letchworth) Limited

Directors and other information


	Directors	Dr M A Slattery
		Mr M W Seaman-Hill
		Mr J J Hill


	Company number	04165193


	Registered office	First Floor Offices
		99 Bancroft
		Hitchin
		Hertfordshire
		SG5 1NQ


	Accountants	Hicks and Company
		Chartered accountants
		First Floor
		99 Bancroft
		Hitchin
		Hertfordshire
		SG5 1NQ




	Bankers	HSBC
		1 Market Place
		Hitchin
		Hertfordshire
		SG5 1DR

Curtis Medical Investments (Letchworth) Limited

Chartered accountants report to the board of directors on the preparation of the

unaudited statutory financial statements of Curtis Medical Investments (Letchworth) Limited

Year ended 31 December 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Curtis Medical Investments (Letchworth) Limited for the year ended 31 December 2024 which comprise the statement of financial position, statement of changes in equity and related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.

This report is made solely to the board of directors of Curtis Medical Investments (Letchworth) Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Curtis Medical Investments (Letchworth) Limited and state those matters that we have agreed to state to the board of directors of Curtis Medical Investments (Letchworth) Limited as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Curtis Medical Investments (Letchworth) Limited and its board of directors as a body for our work or for this report.

It is your duty to ensure that Curtis Medical Investments (Letchworth) Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Curtis Medical Investments (Letchworth) Limited. You consider that Curtis Medical Investments (Letchworth) Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of Curtis Medical Investments (Letchworth) Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Hicks and Company

Chartered accountants

First Floor

99 Bancroft

Hitchin

Hertfordshire

SG5 1NQ

18 September 2025

Curtis Medical Investments (Letchworth) Limited

Statement of financial position

31 December 2024

		2024		2023
	Note	£	£	£	£

Fixed assets
Tangible assets	5	475,000		475,000
		_______		_______
			475,000		475,000

Current assets
Debtors	6	5,572		10,247
Cash at bank		32,102		3,661
		_______		_______
		37,674		13,908
Creditors: amounts falling due
within one year	7	( 323,564)		( 88,032)
		_______		_______
Net current liabilities			( 285,890)		( 74,124)
			_______		_______
Total assets less current liabilities			189,110		400,876

Creditors: amounts falling due
after more than one year	8		-		( 256,020)
			_______		_______
Net assets			189,110		144,856
			_______		_______

Capital and reserves
Called up share capital			100		100
Profit and loss account			189,010		144,756
			_______		_______
Shareholders funds			189,110		144,856
			_______		_______

For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors responsibilities:

- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;

- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

These financial statements were approved by the board of directors and authorised for issue on 18 September 2025 , and are signed on behalf of the board by:

Mr J J Hill

Director

Company registration number: 04165193

Curtis Medical Investments (Letchworth) Limited

Statement of changes in equity

Year ended 31 December 2024

	Called up share capital	Profit and loss account	Total
	£	£	£


At 1 January 2023	100	399,574	501,892

Profit/(loss) for the year		( 357,036)	( 357,036)
Other comprehensive income for the year:
Fair value adjustment to investment property	-	102,218	-
	_______	_______	_______
Total comprehensive income for the year	-	( 254,818)	( 357,036)

	_______	_______	_______
At 31 December 2023 and 1 January 2024	100	144,756	144,856

Profit/(loss) for the year		44,254	44,254
	_______	_______	_______
Total comprehensive income for the year	-	44,254	44,254

	_______	_______	_______
At 31 December 2024	100	189,010	189,110
	_______	_______	_______

Curtis Medical Investments (Letchworth) Limited

Notes to the financial statements

Year ended 31 December 2024

1. General information

The company is a private company limited by shares, registered in England & Wales. The address of the registered office is First Floor Offices, 99 Bancroft, Hitchin, Hertfordshire, SG5 1NQ.

2. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of investment properties measured at fair value through profit or loss.The financial statements are prepared in sterling, which is the functional currency of the entity.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Turnover

Turnover represents the rents of properties and recharged expenses which are included on an accruals basis excluding value added tax.

Taxation

The taxation expense represents the amount of current tax recognised in the reporting period. Tax is recognised in the statement of comprehensive Income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively.Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Tangible assets

tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.

Investment property

Investment property is measured initially at cost, which includes purchase price and any directly attributable expenditure. Investment property is revalued to its fair value at each reporting date and any changes in fair value are recognised in profit or loss.

Impairment

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.

Financial instruments

A financial asset or a financial liability is recognised only when the entity becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.Debt instruments are subsequently measured at amortised cost.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 3 (2023: 3 ).

5. Tangible assets

	Long leasehold property	Total
	£	£
Cost
At 1 January 2024 and 31 December 2024	475,000	475,000
	_______	_______
Depreciation
At 1 January 2024 and 31 December 2024	-	-
	_______	_______
Carrying amount
At 31 December 2024	475,000	475,000
	_______	_______
At 31 December 2023	475,000	475,000
	_______	_______

Investment property

The fair value of the long leasehold investment property has been arrived at on the basis of a valuation carried out by the directors of the company. The valuation was made on an open market value basis for existing use on 31 December 2024.

Tangible assets held at valuation

In respect of tangible assets held at valuation, the aggregate cost, depreciation and comparable carrying amount that would have been recognised if the assets had been carried under the historical cost model are as follows:


	Long leasehold property	Total
	£	£
At 31 December 2024
Aggregate cost	772,782	772,782
Aggregate depreciation	-	-
	_______	_______
Carrying amount	772,782	772,782
	_______	_______

At 31 December 2023
Aggregate cost	772,782	772,782
Aggregate depreciation	-	-
	_______	_______
Carrying amount	772,782	772,782
	_______	_______

6. Debtors

	2024	2023
	£	£
Rents and insurance in arrears	-	3,404
Other debtors	5,572	6,843
	_______	_______
	5,572	10,247
	_______	_______

7. Creditors: amounts falling due within one year

	2024	2023
	£	£
Bank loan (secured)	253,261	42,153
Rents and insurance in advance	23,087	-
Corporation tax	10,751	10,201
Social security and other taxes	8,273	-
Other creditors	28,192	35,678
	_______	_______
	323,564	88,032
	_______	_______

The bank loan is secured by a first charge over the long leasehold investment property.

8. Creditors: amounts falling due after more than one year

	2024	2023
	£	£
Bank loans (secured)	-	256,020
	_______	_______

The bank loan is secured by a first charge over the long leasehold investment property.

9. Directors advances, credits and guarantees

	Balance brought forward and o/standing	Balance brought forward and o/standing
	2024	2023
	£	£
Dr M A Slattery	11,000	11,000
	_______	_______

The above loan is unsecured, interest free and repayable on demand.

10. Related party transactions

Included in other creditors is an amount due to a company in which certain directors have an interest:Curtis Medical Investments Limited £11,000 (2023 £18,000)The above loan is unsecured, interest free and repayable on demand.